vimarsana.com
Home
Live Updates
Ascentage Pharma Passes GMP Compliance Audit by EU QP with Zero Deficiency, in an Achievement Signaling Global Recognition of the Companys Quality Management System : vimarsana.com
Ascentage Pharma Passes GMP Compliance Audit by EU QP with Zero Deficiency, in an Achievement Signaling Global Recognition of the Company's Quality Management System
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
Related Keywords
China ,
Hong Kong ,
Suzhou ,
Jiangsu ,
Rockville ,
Western Australia ,
Australia ,
Prnewswire Ascentage Pharma ,
Ascentage Pharma ,
Dajun Yang ,
Ascentage Pharma Global Manufacturing Center ,
Md Anderson Cancer Center ,
European Union ,
Dana Farber Cancer Institute ,
European Council Directive ,
Global Manufacturing Center ,
Major National ,
National Reimbursement Drug List ,
China National Medical Products Administration ,
Astrazeneca ,
Qualified Person ,
Eudralex Volume ,
Good Manufacturing Practice ,
Medicinal Products ,
Veterinary Use ,
Drug Manufacturing License ,
International Council ,
Technical Requirements ,
Human Use ,
Global Manufacturing ,
Main Board ,
Stock Exchange ,
Hong Kong Limited ,
Major National Rd Projects ,
Major New Drug Projects ,
New Drug Incubator ,
Innovative Drug Programs ,
Major Project ,
Priority Review ,
Breakthrough Therapy ,
Drug Evaluation ,
Reimbursement Drug List ,
Orphan Drug Designation ,
Fast Track Designation ,
Orphan Designation ,
Cancer Center ,
Mayo Clinic ,
vimarsana.com © 2020. All Rights Reserved.